Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
China flag China · Delayed Price · Currency is CNY
10.72
-0.48 (-4.29%)
Nov 13, 2026, 3:00 PM CST

SHA:688553 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
129.16-24.96325.39139.79248.99445.86
Depreciation & Amortization
90.3290.3279.8463.8853.1141.13
Other Amortization
2.012.010.920.71--
Loss (Gain) From Sale of Assets
-0-00.3---0
Asset Writedown & Restructuring Costs
0.120.129.58-0.036.84
Loss (Gain) From Sale of Investments
166.53166.53-253.67-40.62-45.22-19
Provision & Write-off of Bad Debts
1.991.99-0.042.871.64-
Other Operating Activities
-122.334.618.116.2611.312.17
Change in Accounts Receivable
-41.96-41.96-20.27-23.94-41.61-23.86
Change in Inventory
-110.2-110.2-12.8810.568.95-87.04
Change in Accounts Payable
36.1236.1273.37-72.57-27.1673.54
Change in Other Net Operating Assets
1.291.291.983.91-1.5710.83
Operating Cash Flow
117.790.51242.9666.93194.06446.36
Operating Cash Flow Growth
5.20%-62.74%262.98%-65.51%-56.52%15.06%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-62.82-105.27-128.18-296.72-461.61-433.45
Sale of Property, Plant & Equipment
0.220.30.10.04-0
Investment in Securities
-46.81195.17377.98494.17238-1,439
Other Investing Activities
45.7840.5920.5535.8642.58-
Investing Cash Flow
-63.63130.79270.46233.35-181.03-1,872

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-634.15656.39484.94515.05
Long-Term Debt Issued
----12.451.1
Total Debt Issued
819.2634.15656.39484.957.4516.15
Short-Term Debt Repaid
--215-170-106.47-13.2-1
Long-Term Debt Repaid
--387.13-329.54-7.02-54.08-21.24
Lease Payments
-2.03-2.03-3.04-7.02-4.08-6.82
Total Debt Repaid
-630.36-602.13-499.54-113.48-67.28-22.24
Net Debt Issued (Repaid)
188.8432.02156.86371.42-9.83-6.08
Issuance of Common Stock
-----2,373
Repurchase of Common Stock
---30.02---
Common Dividends Paid
-99.64-199.07-98.14-98.12-90.16-0.69
Other Financing Activities
186.49267-115-151--19.23
Financing Cash Flow
275.6999.95-86.3122.3-99.992,347

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-9.49-0.730.071.64-0.16-0.04
Net Cash Flow
320.27320.52427.18424.22-87.12921.45

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
54.88-14.76114.78-229.79-267.5512.91
Free Cash Flow Growth
352.03%-----94.36%
Free Cash Flow Margin
4.89%-1.48%10.49%-24.79%-17.92%0.71%
Free Cash Flow Per Share
0.07-0.020.18-0.37-0.430.02
Levered Free Cash Flow
-10.24-158.7850.34-265.69-350.12-147.17
Unlevered Free Cash Flow
-2.3-152.6758.09-261.5-349.38-146.51
Free Cash Flow After Leases
52.85-16.79111.74-236.8-271.636.09

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
12.8321.1138.6816.8365.7688.39
Change in Working Capital
-150.1-150.172.52-105.94-75.79-30.63